As of Sep 22
| +0.02 / +1.19%|
The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +194.12% increase from the last price of 1.70.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.